MedPage Today December 4, 2024
Jeremy Faust

— Experts tackle access, equity, and the blockbuster drugs reshaping healthcare

In part one of this three-part Instagram Live discussion, MedPage Today editor-in-chief Jeremy Faust, MD, talks about how GLP-1 receptor agonists are transforming diabetes and obesity care in a discussion with Karl Nadolsky, DO, a clinical endocrinologist and obesity specialist at Holland Hospital in Michigan, and Fatima Cody Stanford, MD, MPH, an associate professor of medicine and pediatrics at Massachusetts General Hospital and Harvard Medical School in Boston.

Following is a partial transcript of the video (note that errors are possible):

Faust: I just want to start, first of all, by thanking the two of you because, I think, maybe 2 years ago when we first did this session,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Pharma / Biotech, Trends
How has U.S. Spending on Health Care Changed Over Time?
Merck enters $2B licensing deal for weight loss drug
How Medicare Negotiated Drug Prices Compare to Other Countries
5 Of The Most Important Medical Breakthroughs Of 2024
The Fed's Warnings On Inflation Are Bad News For Biotech Startups

Share This Article